- Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
- Edwards Lifesciences to Sell Critical Care to BD
- Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability
- Edwards Lifesciences Reports First Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
- Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
More ▼
Key statistics
On Tuesday, Edwards Lifesciences Corp (EW:NYQ) closed at 91.23, -5.09% below its 52-week high of 96.12, set on Mar 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 90.00 |
---|---|
High | 91.36 |
Low | 89.80 |
Bid | -- |
Offer | -- |
Previous close | 91.23 |
Average volume | 4.29m |
---|---|
Shares outstanding | 602.60m |
Free float | 597.19m |
P/E (TTM) | 38.79 |
Market cap | 54.38bn USD |
EPS (TTM) | 2.33 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 00:00 BST.
More ▼